FDA clears Auron’s AUTX-703 IND to treat haematological malignancies
Concurrently, the company also secured a funding of $27m in Series B round. The proceeds are set to be utilised for progressing the therapy through a Phase I
Norgine Pharmaceuticals has launched Pedmarqsi (sodium thiosulfate injection) commercially in Germany.
Sanofi Ventures and EQT Life Sciences jointly led the funding round. New investors like Novartis Venture Fund, RiverVest Venture Partners, Mirae Asset Financial Group, abrdn-managed funds, GHR Foundation,